Search Articles — Sudonull

https://sudonull.com/openrna-coordination-layer-for-mrna-vaccines-in-oncology

How the open-source project OpenRNA solves the problem of orchestrating clinical processes for personalized mRNA vaccines. Domain ports, regulatory compliance, support for RNA modalities.

https://sudonull.com/laser-microscope-0-1-nm-for-oncology-and-ics

Learn about the laser microscope with 0.1 nm resolution: testing completed, application in cancer drug development and chip topology control. Technical details and comparisons.

https://sudonull.com/daraxonacib-for-pancreatic-cancer-risks-and-survival

The drug daraxonacib doubled survival in pancreatic cancer but does not cure. Learn about mechanisms, side effects, and real limits of the breakthrough. Read the analysis.

https://sudonull.com/replacement-of-gold-nanoparticles-for-laser-cancer-treatment-in-russia

Russian scientists replaced expensive gold with tungsten and palladium diselenides for photothermal cancer therapy. Learn about a cheap and safe method for destroying inoperable tumors.

https://sudonull.com/oncolytics-biotech-immunotherapy-for-pancreatic-cancer-asco-2026

Oncolytics Biotech data at ASCO 2026: pelareorep virus activates T cells against mutant KRAS in pancreatic cancer. Learn about the breakthrough in treating 'cold' tumors.

https://ymaho.com/blood-test-for-mapping-tumor-microenvironment-a-breakthrough-in-oncology

Learn about the new LiquidTME blood test that uses AI to determine the tumor microenvironment and predict response to immunotherapy. A breakthrough in cancer diagnostics.

https://ymaho.com/breakthrough-technologies-in-oncology-shift-to-protac-and-car-t

Nature records a paradigm shift: oncology moves from inhibitors to PROTAC and cell therapy. Find out who wins in the new race and what awaits the market.

https://ymaho.com/1700-new-microproteins-in-dna-a-breakthrough-in-oncology

Scientists have found 1700+ microproteins in 'junk' DNA. Disabling 6 of them kills up to 85% of cancer cells. Find out how this will change cancer therapy.

https://ymaho.com/first-mrna-vaccine-against-lung-cancer-from-biontech

BioNTech's personalized mRNA therapy against NSCLC is on the way. The vaccine reduces the risk of melanoma recurrence by 49%. Learn about the future of personalized oncology.

https://ymaho.com/a-mechanism-for-overcoming-drug-resistance-in-cancer-has-been-discovered

Scientists have found a way to sensitize head and neck cancer cells to death. The combination of b-AP15 and TRAIL causes the tumor to self-destruct through JNK signaling. Read about the breakthrough in oncology.

https://ymaho.com/nanotechnology-against-cancer-chemoresistance-a-review-from-eur-j-cancer

Breakthrough in oncology: how nanoparticles and CRISPR epigenome editing reverse tumor resistance to chemotherapy. Learn about clinical successes in 2026.

https://ymaho.com/spatial-transcriptomics-a-new-technology-for-identifying-cellular-neighborhoods-in-tumors

Scientists have developed a spatial transcriptomics technology to identify nine types of cellular microenvironments in tumors. Learn how the LiquidTME blood test predicts response to immunotherapy and changes oncology.

https://ymaho.com/ai-predicts-meningioma-recurrence-without-genetics-2026-analysis

Mayo Clinic created AI analyzing tumor slides to predict meningioma recurrence without DNA methylation. Accuracy comparable to genetics. Learn how this changes neuro-oncology.

https://ymaho.com/protac-drug-vepdegestrant-approved-for-breast-cancer

FDA has approved the first PROTAC drug vepdegestrant (Veppanu) for the treatment of breast cancer. Learn how proteolysis-targeting chimera reduces the risk of progression by 43% and opens a new era in oncology.

https://ymaho.com/new-microproteins-in-junk-dna-1700-peptideins-reveal-targets-for-immunotherapy

TransCODE scientists discovered over 1700 microproteins in non-coding DNA. Silencing the OLMALINC gene reduces cancer cell survival by 85%. Learn how peptideins are changing oncology and immunotherapy.